Henry Ford Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).
Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.
Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.
Top-decile sponsor footprint
Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
234 total, page 1 of 5
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
NCT07646197
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
NCT06948552
The Use of Multiple Sensors to Track Sleep in Nightshift Workers
NCT06670287
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NCT06269510
Michigan Initial Experience Using Tigertriever for Thrombectomy
NCT07363525
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
NCT07348367
Radioembolization Versus External Radiation Therapy
NCT07530172
Bright Light Therapy on Sleep Health in Lung Cancer Patients
NCT07064395
Post-incision Antimicrobial Wash vs C. Acnes in Shoulder Arthroplasty
NCT06831422
Restorative Early Sleep Treatment After the Emergency Department
NCT07121270
Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey
NCT06822647
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer
NCT05958082
Sleep to Reduce Incident Depression Effectively in Peripartum
NCT06430333
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
NCT06065371
Intraoral Hypothermia Device for Preserving Taste During Radiation
NCT06579248
Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures
NCT06113211
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
NCT06506344
Parent-Child Memory Study: Improving Future Thinking Among Mothers
NCT06145919
Project 4: ACHIEVE PATHFINDER
NCT06070428
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
NCT07037888
Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation
NCT06149780
A Pilot of a Personalized Circadian mHealth to Improve Sleep in Night Shift Workers
NCT06809335
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
NCT05965310
CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
NCT05718791
Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)
NCT05753891
Project 2: ACHIEVE- HF
NCT05330221
Role of Sleep Reactivity in Shift Work Disorder
NCT05424406
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
NCT05686798
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
NCT05509933
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
NCT05426928
Bioinductive Patch for Full-Thickness Rotator Cuff Tears
NCT05439850
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities
NCT05182372
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
NCT04886726
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
NCT05023772
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies
NCT04737239
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
NCT04623424
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
NCT04233749
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
NCT03850418
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
NCT03718637
Nonopioid Analgesia After Labral Surgery
NCT03825809
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
NCT05526079
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
NCT03850366
Evaluation of Breast Reduction Techniques
NCT04509037
Prenatal Yoga to Prevent Postpartum Depression
NCT06004232
Ascertaining Longterm Outcomes of Fibroid Treatments
NCT06430320
Future Thinking to Improve Parent-Child Relationships
NCT05963633
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
NCT05766683
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE)
NCT05356364
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
NCT05800951
Opioid-Free Pain Protocol After Shoulder Arthroplasty
NCT05488847
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 23 |
| Phase 3 | 9 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Henry Ford Health System pipeline
43 recruiting of 234 indexed (18% open); 148 completed (63%).
Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Insomnia (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Henry Ford Health System: open-pipeline peers nationwide
Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 234 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Brown University · 231 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- New York Institute of Technology · 18% recruiting · 49 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this Henry Ford Health System page
234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.
- 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.